
Glenmark Pharmaceuticals Launches GLIPIQ (Semaglutide) in India
Mumbai: Glenmark Pharmaceuticals Ltd (Glenmark), a research-led, global pharmaceutical company, announced the launch of GLIPIQⓇ (semaglutide) in India for the management of Type
Be Ahead With Economy And Policy Updates

Mumbai: Glenmark Pharmaceuticals Ltd (Glenmark), a research-led, global pharmaceutical company, announced the launch of GLIPIQⓇ (semaglutide) in India for the management of Type

Ahmedabad: Zydus Lifesciences Limited (including its subsidiaries, hereafter referred to as “Zydus”), an innovation led global lifesciences company, has launched Semaglutide Injection under the

Mumbai: Alkem Laboratories Ltd. announced the launch of semaglutide injection in India under the brand names “Semasize”, Obesema” and “Hepaglide” on Saturday. Semaglutide is

Mumbai: Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” and includes its subsidiaries and/or associate companies)

Hyderabad: NATCO Pharma Limited (“NATCO”) announces launch of Semaglutide Injection (multi dose vials) in the India market tomorrow on Day 1 of patent expiry.

Ahmedabad: Zydus Lifesciences Limited (Zydus), an innovation-led life-sciences company with subsidiaries/affiliates in India and across the globe, has entered into a Licensing and

Ahmedabad: Zydus Lifesciences Limited., (“Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) for Cevimeline Hydrochloride Capsules 30

New Delhi: Apollo (NYSE: APO) today announced that Apollo-managed funds, affiliates and other long-term investors have purchased $500 million of investment-grade rated senior

New Delhi: Alembic Pharmaceuticals Limited (“Alembic”) today announced the first prescription-based sale of Pivya® (pivmecillinam) tablets, an oral prescription antibiotic, following its recent

Greater Noida: Eugia Pharma Specialities Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has launched Pomalidomide Capsules, 1 mg, 2 mg, 3
Newsletter

Persistent Wins CII Award for Excellence in Disability Inclusion

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Binimetinib Tablets, 45 mg

BCPL Railway Infra Bags Rs. 46.18 Million Work Under Sealdah Division of Eastern Railway

Intense Technologies Announces Retirement of Founder C.K. Shastri

ACS Technologies Achieves CMMI Maturity Level 3 Appraisal For DEV and SVC Domains
